Teva Pharmaceuticals · 2 hours ago
Director Strategic Workforce Planning & Analytics
Teva Pharmaceuticals is a leading manufacturer of generic medicines committed to making health more affordable and accessible. The role of Director Strategic Workforce Planning & Analytics involves driving workforce planning and reporting processes to ensure client units have the necessary talent and capabilities to meet business needs.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Co-develop and implement global workforce planning processes, systems, best practices and frameworks
Integrate workforce planning processes with the organization’s broader strategic and financial objectives
Analyze the current workforce to identify skills, capabilities, competencies, and potential gaps
Forecast workforce demand considering business growth, emerging skill needs, and market trends
Bring external perspectives on talent and skills to enhance workforce plans and talent supply strategies
Drive insights to HR and business leaders through Controlling and People Analytics activities across the business units and in alignment with the strategy
Apply predictive analytics to workforce data to anticipate risks (e.g., turnover, skill gaps) and create proactive talent plans
Develop contingency plans for unforeseen workforce challenges
Ensure compliance with data privacy and regulatory standards (e.g., GDPR, HIPAA where applicable)
Partner with Talent Acquisition, Learning & Development, Finance, and IT to align workforce plans with hiring, training, and budget strategies
Qualification
Required
Education in business administration, economics, human resources or similar
HR leadership experience, with a focus on strategy, workforce planning, and analytics
Proven track record of driving organizational change and implementing data-driven HR practices
Strong expertise in workforce planning, headcount and cost of labor budgeting and forecasting, and predictive analytics
Demonstrated ability to contribute to financial planning processes from a SWP&A perspective and align initiatives with Long-Range Planning (LRP) and Annual Operating Plan (AOP) objectives
Advanced experience with HR management systems (e.g. SAP SuccessFactors), SAP BI, visualization tools (e.g. Tableau or Power BI), Workforce planning systems (Anaplan, Visier etc) controlling tools (e.g. HFM) as well as MS Office
Ability to translate data insights into actionable workforce strategies and stories
Strong understanding of data governance standards and practices
Possess extensive change management experience, particularly in managing large-scale, fast-paced projects, both independently and guiding others
Ability to operate at both a strategic and operational level within a complex matrix organization and manage diverse stakeholder relationships
Oral and written fluency in English
Benefits
Comprehensive Health Insurance: Medical, Dental, Vision, and Prescription coverage starting on the first day of employment, providing the employee enrolls.
Retirement Savings: 401(k) with employer match, up to 6% and an annual 3.75% Defined Contribution to the 401k plan.
Time Off: Paid Time Off including vacation, sick/safe time, caretaker time and holidays.
Life and Disability Protection: Company paid Life and Disability insurance.
Additional benefits include, but are not limited to, Employee Assistance Program, Employee Stock Purchase Plan, Tuition Assistance, Flexible Spending Accounts, Health Savings Account, Life Style Spending Account, Volunteer Time Off, Paid Parental Leave, if eligible , Family Building Benefits, Virtual Physical Therapy, Accident, Critical Illness and Hospital Indemnity Insurances, Identity Theft Protection, Legal Plan, Voluntary Life Insurance and Long Term Disability and more.
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
Funding
Current Stage
Public CompanyTotal Funding
$5.01BKey Investors
Royalty PharmaBerkshire Hathaway
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
2023-02-27Post Ipo Debt· $2.25B
Leadership Team
Recent News
2025-12-25
2025-12-24
Company data provided by crunchbase